Bitcoin News Update: Propanc’s Cryptocurrency-Driven Cancer Initiative Encounters Doubt from Investors, Stock Falls by 10.5%
- Australia-based Propanc Biopharma secured up to $100M from Hexstone Capital to build a crypto treasury and advance its cancer therapy PRP, targeting first-in-human trials by 2026. - The funding strategy reflects a growing trend in biotech to leverage crypto assets for non-dilutive capital, with Hexstone’s portfolio including Bitcoin , Ether , and Solana . - CEO James Nathanielsz called the move "transformative," aiming to diversify Propanc’s assets while tying capital to clinical milestones, though share
Headquartered in Australia,
This financing approach mirrors a rising trend among biotech companies turning to crypto treasuries as traditional capital markets become more challenging. Firms such as Sonnet BioTherapeutics and Sharps Technology have also embraced digital asset strategies to attract investors and diversify their funding streams
Hexstone Capital, which has supported other crypto treasury projects, has not specified which digital assets Propanc intends to purchase. Still, its holdings include Bitcoin (BTC), Ether (ETH),
The broader landscape for crypto treasury firms has encountered difficulties, with companies like Strategy and Metaplanet seeing notable drops in market capitalization
Propanc’s combined focus on cancer research and digital assets places it at the crossroads of two rapidly expanding industries. Preclinical studies of PRP have demonstrated a 70% reduction in tumor size in animal tests
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitwise’s Chainlink ETF Listed on DTCC as Institutional Interest in LINK Rises

Visa Launches Program to Speed Cross-Border Payments via Stablecoins

Solana News Update: Clearer Regulations Help Crypto Yields Close the Gap with Traditional Finance
- Crypto's yield gap with TradFi narrows as LSTs and RWAs drive innovation, with stablecoins and tokenized assets bridging the 8-11% vs. 55-65% disparity. - U.S. GENIUS Act boosted institutional trust in yield-bearing stablecoins by enforcing collateral rules and AML compliance, spurring 300% YoY market growth. - Circle's 4.15% reserve returns and $740M Q3 revenue highlight stablecoin profitability, while embedded solutions make adoption "invisible" in consumer apps. - DeFi crises like xUSD depegging cause

Bostic's Departure Under Political Scrutiny Challenges the Federal Reserve's Autonomy
- Atlanta Fed President Raphael Bostic announced his retirement in November 2025, stepping down in February 2026 after nearly nine years as the first Black and openly gay Fed regional bank leader. - His tenure emphasized economic equity post-2020 protests and cautious inflation management, supporting two 2025 rate cuts while urging restraint to return to the 2% inflation target. - Bostic's exit coincides with Trump administration pressure for lower rates and potential influence over regional banks , testin
